UC Davis surgeon pioneers dual chamber leadless pacemaker in 13-year-old patient

UC Davis Director of Pediatric Electrophysiology Dan Cortez has set another world record: He is the first to implant a dual chamber leadless pacemaker in a child.

Iovance’s $211M offering; Almirall licenses Novo drug; AstraZeneca files Dato-DXd; Sonata layoffs

Plus other news you may have missed from the FTC, Everest, Gilead, IsomAb, Oramed, Innovent, Sonata, Larimar and Immunome. Iovance Biotherapeutics offers $211M in shares:

February 21, 2024

Editas and Genevant team up to develop gene editing therapies – Pharmaceutical Technology

Genevant LNP technology will provide a vehicle for Editas’ CRISPR/Cas12a gene therapy. Credit: ART-ur / Shutterstock. Editas Medicine and Genevant Sciences will collaborate to develop

October 22, 2024

What to know about home care services

Most older Americans want to live at home as long as they can, but finding and affording the help they need often isn’t easy.

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.